Matches in SemOpenAlex for { <https://semopenalex.org/work/W2505859400> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2505859400 endingPage "4848" @default.
- W2505859400 startingPage "4848" @default.
- W2505859400 abstract "Abstract We previously discovered a novel 2-aryl-4-benzoyl-imidazole (ABI) scaffold exerts its potent anti-proliferative effects through interacting with the colchicine binding site in tubulin. Extensive structure-activity relationship (SAR) studies of this novel scaffold showed that the best analog in this series, ABI-231, has an average IC50 = 5.2 nM against panels of melanoma and prostate cancer cell lines, is orally bioavailable, and strongly suppress melanoma tumors in vivo. Analyses of the potential binding pose of ABI-231 at the colchicine binding pocket suggested small substitutions to the indole moiety in ABI-231 could further increase its interactions to tubulin. Based this hypothesis, we have established an efficient synthetic method for the synthesis of ABI-231 analogs by either rotating the indole ring or introducing substituents on the indole of ABI-231. Using this method, we synthesized and tested 27 analogs of ABI-231. Several of the compounds show excellent potency against a panel of melanoma cancer cell lines with a diverse genomic background (mutations in BRAF, TP53, CDKN2A and PTEN) that are frequently encountered in clinical metastatic melanoma tumors. Additionally, they are not substrates for the P-glycoprotein (Pgp) efflux pump and therefore strongly inhibited the multidrug resistant cell lines. The potency of the compounds was further verified by their potent growth inhibition of cancer cell colonies. Results from cell cycle analysis, apoptosis evaluation and tubulin polymerization inhibition are consistent with their expected mechanisms of action. Potential off-target analyses performed by Eurofins Cerep-Panlabs SafetyScreen 44 indicated that they are clean and does not inihibt any of the tested off-targets at 100 fold of its IC50 value in melanoma cells, suggesting the good safety profile for this compound and the probably these scaffold in general. We are currently performing in vivo efficacy studies for the most potent analogs. These compounds hold great promise as a new generation of orally available tubulin inhibitors. Citation Format: Wang Qinghui, Arnst E. Kinsie, Duane D. Miller, Wei Li. Discovery of ABI-231 analogs targeting the colchicine site in tubulin for advanced melanoma. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4848." @default.
- W2505859400 created "2016-08-23" @default.
- W2505859400 creator A5000432967 @default.
- W2505859400 creator A5004219097 @default.
- W2505859400 creator A5016676195 @default.
- W2505859400 creator A5044705368 @default.
- W2505859400 date "2016-07-15" @default.
- W2505859400 modified "2023-10-16" @default.
- W2505859400 title "Abstract 4848: Discovery of ABI-231 analogs targeting the colchicine site in tubulin for advanced melanoma" @default.
- W2505859400 doi "https://doi.org/10.1158/1538-7445.am2016-4848" @default.
- W2505859400 hasPublicationYear "2016" @default.
- W2505859400 type Work @default.
- W2505859400 sameAs 2505859400 @default.
- W2505859400 citedByCount "1" @default.
- W2505859400 countsByYear W25058594002023 @default.
- W2505859400 crossrefType "journal-article" @default.
- W2505859400 hasAuthorship W2505859400A5000432967 @default.
- W2505859400 hasAuthorship W2505859400A5004219097 @default.
- W2505859400 hasAuthorship W2505859400A5016676195 @default.
- W2505859400 hasAuthorship W2505859400A5044705368 @default.
- W2505859400 hasConcept C126322002 @default.
- W2505859400 hasConcept C150903083 @default.
- W2505859400 hasConcept C185592680 @default.
- W2505859400 hasConcept C190283241 @default.
- W2505859400 hasConcept C192527728 @default.
- W2505859400 hasConcept C20418707 @default.
- W2505859400 hasConcept C207001950 @default.
- W2505859400 hasConcept C2776636253 @default.
- W2505859400 hasConcept C2777609662 @default.
- W2505859400 hasConcept C2777658100 @default.
- W2505859400 hasConcept C502942594 @default.
- W2505859400 hasConcept C55493867 @default.
- W2505859400 hasConcept C71240020 @default.
- W2505859400 hasConcept C71924100 @default.
- W2505859400 hasConcept C84425145 @default.
- W2505859400 hasConcept C86554907 @default.
- W2505859400 hasConcept C86803240 @default.
- W2505859400 hasConcept C95444343 @default.
- W2505859400 hasConcept C98274493 @default.
- W2505859400 hasConceptScore W2505859400C126322002 @default.
- W2505859400 hasConceptScore W2505859400C150903083 @default.
- W2505859400 hasConceptScore W2505859400C185592680 @default.
- W2505859400 hasConceptScore W2505859400C190283241 @default.
- W2505859400 hasConceptScore W2505859400C192527728 @default.
- W2505859400 hasConceptScore W2505859400C20418707 @default.
- W2505859400 hasConceptScore W2505859400C207001950 @default.
- W2505859400 hasConceptScore W2505859400C2776636253 @default.
- W2505859400 hasConceptScore W2505859400C2777609662 @default.
- W2505859400 hasConceptScore W2505859400C2777658100 @default.
- W2505859400 hasConceptScore W2505859400C502942594 @default.
- W2505859400 hasConceptScore W2505859400C55493867 @default.
- W2505859400 hasConceptScore W2505859400C71240020 @default.
- W2505859400 hasConceptScore W2505859400C71924100 @default.
- W2505859400 hasConceptScore W2505859400C84425145 @default.
- W2505859400 hasConceptScore W2505859400C86554907 @default.
- W2505859400 hasConceptScore W2505859400C86803240 @default.
- W2505859400 hasConceptScore W2505859400C95444343 @default.
- W2505859400 hasConceptScore W2505859400C98274493 @default.
- W2505859400 hasIssue "14_Supplement" @default.
- W2505859400 hasLocation W25058594001 @default.
- W2505859400 hasOpenAccess W2505859400 @default.
- W2505859400 hasPrimaryLocation W25058594001 @default.
- W2505859400 hasRelatedWork W1570951579 @default.
- W2505859400 hasRelatedWork W1967189402 @default.
- W2505859400 hasRelatedWork W1979617034 @default.
- W2505859400 hasRelatedWork W2048106651 @default.
- W2505859400 hasRelatedWork W2051600615 @default.
- W2505859400 hasRelatedWork W2053257219 @default.
- W2505859400 hasRelatedWork W2090345735 @default.
- W2505859400 hasRelatedWork W2505859400 @default.
- W2505859400 hasRelatedWork W2902983040 @default.
- W2505859400 hasRelatedWork W2964734018 @default.
- W2505859400 hasVolume "76" @default.
- W2505859400 isParatext "false" @default.
- W2505859400 isRetracted "false" @default.
- W2505859400 magId "2505859400" @default.
- W2505859400 workType "article" @default.